Mathes Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,765
| Closed | -$648K | – | 135 |
|
|
2016
Q4 | $648K | Sell |
1,765
-1,370
| -44% | -$503K | 0.36% | 69 |
|
|
2016
Q3 | $1.26M | Buy |
3,135
+2,510
| +402% | +$1.01M | 0.71% | 44 |
|
|
2016
Q2 | $218K | Hold |
625
| – | – | 0.13% | 124 |
|
|
2016
Q1 | $226K | Sell |
625
-50
| -7% | -$18.1K | 0.14% | 117 |
|
|
2015
Q4 | $366K | Hold |
675
| – | – | 0.21% | 98 |
|
|
2015
Q3 | $314K | Sell |
675
-75
| -10% | -$34.9K | 0.21% | 100 |
|
|
2015
Q2 | $383K | Sell |
750
-25
| -3% | -$12.8K | 0.2% | 107 |
|
|
2015
Q1 | $350K | Hold |
775
| – | – | 0.18% | 125 |
|
|
2014
Q4 | $318K | Buy |
775
+100
| +15% | +$41K | 0.17% | 132 |
|
|
2014
Q3 | $243K | Buy |
+675
| New | +$243K | 0.12% | 149 |
|